Bergenstal, R. M., Rosenstock, J., Arakaki, R. F., Prince, M. J., Qu, Y., Sinha, V. P., . . . Jacober, S. J. (2012). A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. American Diabetes Association.

Bergenstal, Richard M., Julio Rosenstock, Richard F. Arakaki, Melvin J. Prince, Yongming Qu, Vikram P. Sinha, Daniel C. Howey, ja Scott J. Jacober. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. American Diabetes Association, 2012.

Bergenstal, Richard M., et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. American Diabetes Association, 2012.